Rodman David Malcom sold MLYS
March 17, 2026 · Form 4 insider transaction
Rodman David Malcom sold 417 shares of Mineralys Therapeutics, Inc. at $25.65 per share, a transaction worth $10.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
417
Price
$25.65
Total value
$10.7K
InsiderRodman David Malcom
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 17, 2026
Filing dateMarch 17, 2026
Shares owned after76,140
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.